Sign in

CIK 0001540159

  • Non-accelerated filer
  • Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 905-475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-27 Marshall Patrick Director Grant or award +19,000 71,666
2025-05-29 Marshall Patrick Director Grant or award +11,000 52,666
2025-02-12 Marshall Patrick Director Grant or award +41,666 $1.92 $80K 41,666
2023-07-20 Marshall Patrick Director Grant or award · Share Option (right to buy) +20,000 20,000
2023-07-20 Marshall Patrick Director Grant or award · Share Option (right to buy) +20,000 20,000

Page 1 of 1 · 5 trades